We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Aditxt Inc is a life sciences company which focuses on prolong life and enhance life quality of transplanted patients. The firm develop products designed to induce tolerance to transplanted organs. The firm's immunosuppressive (anti-rejection) drugs has made possible life-saving organ transplantatio... Aditxt Inc is a life sciences company which focuses on prolong life and enhance life quality of transplanted patients. The firm develop products designed to induce tolerance to transplanted organs. The firm's immunosuppressive (anti-rejection) drugs has made possible life-saving organ transplantation procedures as these drugs prevent or delay organ rejection. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) which utilizes tolerogenic approach that utilizes the body's natural process of cell death, to deliver a modified antigen that signals the immune system to become tolerant to transplanted tissues. Show more
Submission for Regulatory Approval to Initiate Human Trials for Type 1 Diabetes, Psoriasis, and Stiff-Person Syndrome Targeted for H2 2025 Aditxt, Inc. (NASDAQ: ADTX) (βAditxtβ or the βCompanyβ...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Courtβs approval allows transaction with Aditxt to proceed, subject to other closing conditions...
Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 PR Newswire SAN DIEGO, Nov. 14, 2024 β Improved loss from operations by 31% β β Acquired SOLOSEC, a commercially...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.00386 | 1.96397679862 | 0.19654 | 0.241 | 0.178 | 7362577 | 0.18864401 | CS |
4 | -0.1647 | -45.1109285127 | 0.3651 | 0.37 | 0.178 | 2725651 | 0.21426311 | CS |
12 | -1.5196 | -88.3488372093 | 1.72 | 1.8599 | 0.178 | 2929646 | 0.62399112 | CS |
26 | -54.5996 | -99.6343065693 | 54.8 | 108 | 0.178 | 3639186 | 21.23590262 | CS |
52 | -202.9996 | -99.9013779528 | 203.2 | 253.6 | 0.178 | 1935313 | 27.62499679 | CS |
156 | -879.7996 | -99.9772272727 | 880 | 45584 | 0.178 | 2151766 | 979.24343164 | CS |
260 | -8447.7996 | -99.9976278409 | 8448 | 45584 | 0.178 | 2284033 | 2395.27404271 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions